Global High Throughput Screening (HTS) Market 2018-2022 - Key Vendors are Agilent Technologies, Bio-Rad Laboratories, Charles River, Merck, PerkinElmer & Thermo Fisher Scientific - ResearchAndMarkets.com

DUBLIN--()--The "Global High Throughput Screening (HTS) Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The global high throughput screening (HTS) market to grow at a CAGR of 7.01% during the period 2018-2022.

Global High Throughput Screening (HTS) Market 2018-2022 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is increasing focus on promotional activities. The nature of the product and the niche end-users makes it difficult for vendors to promote their products. Unlike other products, brand and product visibility have a limited role in the sale of HTS.

According to the report, one driver in the market is rise in R&D investments. The global expenditure on R&D for drug development has shown constant growth in the last few years and has increased by 3.21% from 2016. With growing economies, the developing countries are expected to focus on the disease burden.

Further, the report states that one challenge in the market is shortage of trained professionals. The use of HTS requires skilled personnel. Pharmaceutical and biotechnology manufacturing facilities and laboratories need to manufacture products within a short time span.

Key vendors

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Charles River
  • Merck KGaA
  • PerkinElmer
  • Thermo Fisher Scientific

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Market Sizing

Part 06: Five Forces Analysis

Part 07: Market Segmentation By End-User

Part 08: Customer Landscape

Part 09: Regional Landscape

Part 10: Decision Framework

Part 11: Drivers And Challenges

Part 12: Market Trends

Part 13: Vendor Landscape

Part 14: Vendor Analysis

Part 15: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/7s8chr/global_high?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery